Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, LVS Advisory - Event Driven. This analysis is provided for institutional research purposes only and is not investment advice.
"LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biotech liquidation trades."
For the first half of 2025, LVS Growth Portfolio gained 15.8% (beating the S&P 500's 6.2%) and LVS Event-Driven Portfolio gained 3.6%. The letter outlines two main investment pillars. First, the fund doubled down on its position in Curtiss-Wright (CW) in March 2025, viewing its aerospace/defense and nuclear segments as heavily insulated from competition. LVS believes CW's commercial nuclear business is a mispriced call option set to grow 5x over 5-8 years, propelled by the rising energy needs of AI data centers and greenfield SMR initiatives. Second, LVS outlines its strategy in the biotech liquidation space, where they purchase companies with failed trials trading at steep discounts to cash (e.g., ITOS) and wait for management to return capital to shareholders.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Growth Outlook
Market outlook remains above average conviction: LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Risk Appetite
Risk appetite posture is above average conviction: LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Forward Guidance
Forward guidance signal: LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Language Signal
Tone analysis indicates high conviction language: LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Perceived Risk
Perceived risk level is evaluated as low conviction. LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
Time Horizon
Investment time horizon reflects a high conviction orientation. LVS Advisory delivered strong H1 2025 results, highlighting a double-down on monopolistic defense and nuclear provider Curtiss-Wright, alongside highly profitable, cash-backed biot...
